Location: Tour-de-Peilz, Switzerland Work model: Hybrid Activity Rate: 100% Contract type / duration: Permanent; open to internal and external candidates Target Start date: As soon as possible Together, we make breakfast better. Reporting to the CPW
Strategic Research Operations Location: Lausanne, Switzerland Work model: Hybrid / Full time 100% Contract type / duration: Permanent Shape the future through scientific breakthroughs and innovation. As a Lab Data Technology Specialist at Nestlé Research within our
Job Description The Data Operations Analyst will be supporting Reference Data Function, is responsible for instructions of client deliverables, coding (data categorization) and data input validation focusing on specific industry/category or set of categories (e.g. Beverages, Food, Health and Beauty
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
About IonQ: IonQ, Inc. [NYSE: IONQ] is the world’s leading quantum platform and merchant supplier - delivering integrated quantum solutions across computing, networking, sensing, and security. IonQ’s newest generation of quantum computers, the IonQ Tempo, is
INTERNATIONAL TELECOMMUNICATION UNION ITU is the leading United Nations agency for information and communication technologies, with the mission to connect the world. To achieve this, ITU manages the radio-frequency spectrum and satellite orbits at the international
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Job Description SummaryManage assigned commodities for the Gas Power Heavy Duty New Units business segment (focus on HRSG but not limited to). Support the development of supplier panels that can meet or exceed GEV’s expectations. Negotiate
Our Mission At Palo Alto Networks®, we’re united by a shared mission—to protect our digital way of life. We thrive at the intersection of innovation and impact, solving real-world problems with cutting-edge technology and bold thinking.
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Job Description SummaryManage assigned commodities for the Gas Power Heavy Duty New Units business segment (focus on HRSG but not limited to). Support the development of supplier panels that can meet or exceed GEV’s expectations. Manage
Job Description SummaryManage assigned commodities for the Gas Power Heavy Duty New Units business segment (focus on HRSG but not limited to). Support the development of supplier panels that can meet or exceed GEV’s expectations. Negotiate
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
By joining Bio-Techne, you’ll join a company with a powerful and positive purpose of enabling cutting-edge research in Life Sciences and Clinical Diagnostics. Bio-Techne, and all of its brands, provides tools for researchers to further treat
Company Description With audiences consuming media across multiple devices and platforms, the ability to accurately measure and analyse media consumption is more critical than ever. Our Media Measurement team uses advanced technologies to track what content
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
ARTIDIS AG is a clinical-stage health-tech start-up founded in Basel, Switzerland, that has developed the first nanomechanical biomarker for cancer diagnosis and treatment optimization. The ARTIDIS nanotechnology platform integrates different types of clinical data into the ARTIDISNET digital